Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 242

1.

RIP3 overexpression sensitizes human breast cancer cells to parthenolide in vitro via intracellular ROS accumulation.

Lu C, Zhou LY, Xu HJ, Chen XY, Tong ZS, Liu XD, Jia YS, Chen Y.

Acta Pharmacol Sin. 2014 Jul;35(7):929-36. doi: 10.1038/aps.2014.31. Epub 2014 Jun 9.

3.

AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells.

Rabi T, Huwiler A, Zangemeister-Wittke U.

Mol Carcinog. 2014 Jul;53(7):578-88. doi: 10.1002/mc.22012. Epub 2013 Mar 8.

PMID:
23475563
4.

Paclitaxel sensitivity of breast cancer cells with constitutively active NF-kappaB is enhanced by IkappaBalpha super-repressor and parthenolide.

Patel NM, Nozaki S, Shortle NH, Bhat-Nakshatri P, Newton TR, Rice S, Gelfanov V, Boswell SH, Goulet RJ Jr, Sledge GW Jr, Nakshatri H.

Oncogene. 2000 Aug 24;19(36):4159-69.

5.

Inhibitory effects of mild hyperthermia plus docetaxel therapy on ER(+/-) breast cancer cells and action mechanisms.

Lv F, Yu Y, Zhang B, Liang D, Li ZM, You W.

J Huazhong Univ Sci Technolog Med Sci. 2013 Dec;33(6):870-6. doi: 10.1007/s11596-013-1214-8. Epub 2013 Dec 13.

PMID:
24337851
6.

[Regulation mechanism of breast cancer resistance protein by toremifene to reverse BCRP-mediated multidrug resistance in breast cancer cells].

Zhang YH, Li G, Yu J, Xu MS, Liu ZX.

Zhonghua Zhong Liu Za Zhi. 2011 Sep;33(9):654-60. Chinese.

PMID:
22340044
7.

Antitumor activity of phenethyl isothiocyanate in HER2-positive breast cancer models.

Gupta P, Srivastava SK.

BMC Med. 2012 Jul 24;10:80. doi: 10.1186/1741-7015-10-80.

8.
9.
10.

Suppression of growth, migration and invasion of highly-metastatic human breast cancer cells by berbamine and its molecular mechanisms of action.

Wang S, Liu Q, Zhang Y, Liu K, Yu P, Liu K, Luan J, Duan H, Lu Z, Wang F, Wu E, Yagasaki K, Zhang G.

Mol Cancer. 2009 Oct 1;8:81. doi: 10.1186/1476-4598-8-81.

11.

MAPK signaling mediates sinomenine hydrochloride-induced human breast cancer cell death via both reactive oxygen species-dependent and -independent pathways: an in vitro and in vivo study.

Li X, Wang K, Ren Y, Zhang L, Tang XJ, Zhang HM, Zhao CQ, Liu PJ, Zhang JM, He JJ.

Cell Death Dis. 2014 Jul 31;5:e1356. doi: 10.1038/cddis.2014.321.

12.

CIP2A is a target of bortezomib in human triple negative breast cancer cells.

Tseng LM, Liu CY, Chang KC, Chu PY, Shiau CW, Chen KF.

Breast Cancer Res. 2012 Apr 26;14(2):R68.

13.

Expression and regulatory function of miRNA-182 in triple-negative breast cancer cells through its targeting of profilin 1.

Liu H, Wang Y, Li X, Zhang YJ, Li J, Zheng YQ, Liu M, Song X, Li XR.

Tumour Biol. 2013 Jun;34(3):1713-22. doi: 10.1007/s13277-013-0708-0. Epub 2013 Feb 22.

PMID:
23430586
14.

A diverse induction of apoptosis by trabectedin in MCF-7 (HER2-/ER+) and MDA-MB-453 (HER2+/ER-) breast cancer cells.

Atmaca H, Bozkurt E, Uzunoglu S, Uslu R, Karaca B.

Toxicol Lett. 2013 Aug 14;221(2):128-36. doi: 10.1016/j.toxlet.2013.06.213. Epub 2013 Jun 20.

PMID:
23792433
15.

[Effects of down-regulation of CC chemokine ligand 5 (CCL5) on proliferation of human breast cancer cells in vitro].

Kuang JX, Wang WX, Sun SR, Wang WR, Yao XL.

Zhonghua Zhong Liu Za Zhi. 2011 Mar;33(3):174-7. Chinese.

PMID:
21575514
16.

Different anticancer effects of Saxifragifolin A on estrogen receptor-positive and estrogen receptor-negative breast cancer cells.

Kim KH, Kim JY, Kwak JH, Pyo S.

Phytomedicine. 2015 Aug 15;22(9):820-8. doi: 10.1016/j.phymed.2015.05.057. Epub 2015 Jun 19.

PMID:
26220629
17.
18.

Reduced expression of Toll-like receptor 4 inhibits human breast cancer cells proliferation and inflammatory cytokines secretion.

Yang H, Zhou H, Feng P, Zhou X, Wen H, Xie X, Shen H, Zhu X.

J Exp Clin Cancer Res. 2010 Jul 10;29:92. doi: 10.1186/1756-9966-29-92.

19.

Aryl Hydrocarbon Receptor Ligand 5F 203 Induces Oxidative Stress That Triggers DNA Damage in Human Breast Cancer Cells.

McLean LS, Watkins CN, Campbell P, Zylstra D, Rowland L, Amis LH, Scott L, Babb CE, Livingston WJ, Darwanto A, Davis WL Jr, Senthil M, Sowers LC, Brantley E.

Chem Res Toxicol. 2015 May 18;28(5):855-71. doi: 10.1021/tx500485v. Epub 2015 Apr 1.

20.

The quinoxaline di-N-oxide DCQ blocks breast cancer metastasis in vitro and in vivo by targeting the hypoxia inducible factor-1 pathway.

Ghattass K, El-Sitt S, Zibara K, Rayes S, Haddadin MJ, El-Sabban M, Gali-Muhtasib H.

Mol Cancer. 2014 Jan 24;13:12. doi: 10.1186/1476-4598-13-12.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk